Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05707325 | Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies(Reboot-101) | unknown | Early Phase 1 | 30 | Westlake TherapeuticsINDUSTRY | 1 | Jul 24, 2024 | clinicaltrials |
| NCT06431529 | A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors(Neoantigen-T) | unknown | Early Phase 1 | 6 | JIANG LONGWEIOTHER | 1 | May 28, 2024 |
| clinicaltrials |
| NCT03863145 | Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors | unknown | Early Phase 1 | 90 | Cosmo Technologies LtdINDUSTRY | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05490264 | [68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors | unknown | Early Phase 1 | 20 | SmartNuclide BiopharmaINDUSTRY | 1 | Dec 7, 2023 | clinicaltrials |
| NCT06126705 | 18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor | unknown | Early Phase 1 | 60 | Affiliated Hospital of North Sichuan Medical CollegeOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT05971576 | A Clinical Study on TILs for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Suzhou BlueHorse Therapeutics Co., Ltd.INDUSTRY | 0 | Aug 2, 2023 | clinicaltrials |
| NCT05971589 | A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 5 | Suzhou BlueHorse Therapeutics Co., Ltd.INDUSTRY | 0 | Aug 2, 2023 | clinicaltrials |
| NCT05941936 | A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 5 | Suzhou BlueHorse Therapeutics Co., Ltd.INDUSTRY | 1 | Jul 12, 2023 | clinicaltrials |
| NCT05828238 | Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy | unknown | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Apr 25, 2023 | clinicaltrials |
| NCT05724732 | Exploratory Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Gynecologic Tumors | unknown | Early Phase 1 | 24 | RenJi HospitalOTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05583201 | NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors | unknown | Early Phase 1 | 18 | jianming xuOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05649618 | TIL Cells for the Treatment of the Advanced Solid Tumors Patients | unknown | Early Phase 1 | 42 | Fujian Cancer HospitalOTHER_GOV | 0 | Dec 14, 2022 | clinicaltrials |
| NCT05648994 | TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors | unknown | Early Phase 1 | 30 | Fujian Cancer HospitalOTHER_GOV | 0 | Dec 13, 2022 | clinicaltrials |
| NCT05638828 | A Study of RD14-01 in Patients With Advanced Solid Tumors | unknown | Early Phase 1 | 24 | Shen LinOTHER | 0 | Dec 6, 2022 | clinicaltrials |
| NCT05623891 | Safety Study of 177Lu-Anti-ED-B mAbs SPECT Imaging in Patients With ED-B Positive Solid Tumors | unknown | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Nov 23, 2022 | clinicaltrials |
| NCT05373147 | αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors | unknown | Early Phase 1 | 21 | Shanghai Mengchao Cancer HospitalOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT05515185 | B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors | unknown | Early Phase 1 | 30 | The First People's Hospital of LianyungangOTHER | 1 | Aug 25, 2022 | clinicaltrials |
| NCT05382377 | NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors | unknown | Early Phase 1 | 18 | jianming xuOTHER | 1 | May 19, 2022 | clinicaltrials |
| NCT05287165 | Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms | unknown | Early Phase 1 | 19 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | Mar 18, 2022 | clinicaltrials |
| NCT05284968 | RD07 Cell Injection in the Treatment of Patients With Advanced Claudin18.2 Positive Solid Tumors | unknown | Early Phase 1 | 36 | Peking UniversityOTHER | 0 | Mar 17, 2022 | clinicaltrials |
| NCT05275062 | Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma | unknown | Early Phase 1 | 6 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | Mar 11, 2022 | clinicaltrials |
| NCT05194709 | Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors | unknown | Early Phase 1 | 40 | Wuxi People's HospitalOTHER | 1 | Feb 2, 2022 | clinicaltrials |
| NCT04841421 | Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid Tumors | unknown | Early Phase 1 | 30 | Sinotau Pharmaceutical GroupINDUSTRY | 0 | Apr 12, 2021 | clinicaltrials |
| NCT04076137 | Targeted T-cell Therapy in Solid Tumors | unknown | Early Phase 1 | 10 | Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.INDUSTRY | 1 | Sep 3, 2019 | clinicaltrials |
| NCT03815084 | A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors | unknown | Early Phase 1 | 100 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 0 | Jan 30, 2019 | clinicaltrials |
| NCT03815630 | A Study of PD1 Combined With Dc-cik in the Treatment of Solid Tumors(DC-CIK) | unknown | Early Phase 1 | 100 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 0 | Jan 30, 2019 | clinicaltrials |
Data updated 22 days agoSource updated Jul 24, 2024source: clinicaltrials